Struggling With Great Stock Picks? Discover StockInvest.us Top Gems!
OPKO Health (OPK) reported earnings 30 days ago. What's next for the stock?
In the first three months of 2023, the company posted $237.6 million in revenue, up 28.2% from the previous quarter. In addition to the Merck deal, OPKO received a $7 million payment from Vifor in Q1
Penny stocks to buy for under $1 but are they worth the risk? The post 7 Hot Penny Stocks Under $1.10 To Watch This Week appeared first on Penny Stocks to Buy, Picks, News and Information | PennyStock

Strong Small-Cap Insider Buys: Q1 2023

12:15am, Wednesday, 26'th Apr 2023
Strong Small-Cap Insider Buys: Q1 2023.
MIAMI, April 25, 2023 (GLOBE NEWSWIRE) --  OPKO Health, Inc. (NASDAQ: OPK) plans to report operating and financial results for the three months ended March 31, 2023 after the close of the U.S. financ
When it comes to insider transactions, there are few insiders as consistent  — and successful  — as OPKO Health ( US:OPK , IL:OPK) chairman and CEO Phillip Frost.
Penny stocks with unusual options activity. The post Penny Stocks To Buy Now?
Penny Stocks with unusual options activity. Time to buy or avoid altogether?
OPKO Health's (OPK) entry into a worldwide license and collaboration agreement with Merck is expected to aid in developing a vaccine against EBV.

Why OPKO Health Shares Jumped on Wednesday

04:34pm, Wednesday, 08'th Mar 2023
Drugmaker Merck is supplying OPKO with cash to continue working on an Epstein-Barr vaccine. Although other vaccines aimed at the disease are in various degrees of development, OPKO's ModeX Therapeutic
4 biotech penny stocks to watch right now. The post 4 Top Penny Stocks To Watch With Big Biotech News This Quarter appeared first on Penny Stocks to Buy, Picks, News and Information | PennyStocks.com.
Despite OPKO Health's (OPK) robust RAYALDEE sales and strength in Pharmaceuticals segment, its overall fourth-quarter results reflect soft performances.
OPKO Health, Inc. (NASDAQ:OPK ) Q4 2022 Earnings Conference Call February 23, 2023 4:30 PM ET Company Participants Yvonne Briggs - LHA Investor Relations Phillip Frost - Chairman & CEO Elias Zerhouni
Investors continue to be optimistic about OPKO Health (OPK) owing to its potential in RAYALDEE.
MIAMI, Feb. 16, 2023 (GLOBE NEWSWIRE) -- OPKO Health, Inc. (NASDAQ: OPK) plans to report operating and financial results for the three months ended December 31, 2022 after the close of the U.S. financ
Click to get the best stock tips daily for free!

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE